Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
Is This What the Doctor Ordered for Eli Lilly?
Motley Fool
Thu, 06/27/13 - 08:55 pm
Eli Lilly
diabetes
dulaglutide
JNJ
Merck
Novo Nordisk
Bristol-Myers Squibb
Novo Nordisk Suspends Paula Deen As A Spokesperson
Pharmalot
Thu, 06/27/13 - 11:15 am
Novo Nordisk
Paula Deen
diabetes
New AMA Obesity Ruling Should Push Big Pharma To Find Acquisitions
Seeking Alpha
Thu, 06/27/13 - 09:59 am
obesity
M&A
Oramed
AstraZeneca
MannKind
Merck
Sanofi
Novo Nordisk
New GSK diabetes drug works, but faces tough competition
Reuters
Mon, 06/24/13 - 10:28 am
GSK
diabetes
albiglutide
GLP-1 agonist
Victoza
Byetta
Bydureon
Novo Nordisk
Bristol-Myers Squibb
AstraZeneca
10 Top-selling Diabetes Drugs - 2012
Fierce Pharma
Fri, 06/21/13 - 09:26 am
diabetes
Merck
Januvia
Lantus
Sanofi
NovoRapid
Novo Nordisk
Eli Lilly
Humalog
Victoza
Levemir
Janumet
Novo Mix 30
Takeda
Actos
Novo Nordisk shares hit by concerns over rival diabetes drugs
Reuters
Mon, 06/17/13 - 09:17 am
diabetes
Novo Nordisk
Sanofi
Eli Lilly
dulaglutide
Victoza
Lyxumia
Lantus
Diabetes Drugs Under Scrutiny As FDA Considers Another Study
Pharmalot
Wed, 06/12/13 - 12:40 pm
FDA
diabetes
Merck
Januvia
Onglyza
Bristol-Myers Squibb
Byetta
AstraZeneca
Eli Lilly
Novo Nordisk
Victoza
Tradjenta
Boehringer Ingelheim
Novo Nordisk Is An Undervalued Industry Leading Healthcare Company
Seeking Alpha
Wed, 06/12/13 - 08:53 am
Novo Nordisk
Sanofi steps up diabetes drive as rivals raise the stakes
Reuters
Fri, 06/7/13 - 09:18 am
Sanofi
diabetes
Novo Nordisk
Novo Nordisk Has One of the Widest Moats in Health Care
Yahoo/Morningstar
Thu, 06/6/13 - 10:04 am
Novo Nordisk
diabetes
Doctor’s Doubts Imperil Lucrative Diabetes Drugs
NY Times, NY
Thu, 05/30/13 - 04:51 pm
physicians
diabetes
Bristol-Myers Squibb
Byetta
Merck
AstraZeneca
Januvia
Novo Nordisk
Eli Lilly
Takeda
Boehringer Ingelheim
Is Novo A Threat To Arena, Vivus, And Orexigen?
Seeking Alpha
Thu, 05/30/13 - 09:02 am
obesity
Novo Nordisk
Victoza
Arena Pharmaceuticals
Vivus
Orexigen
Novo obesity drug could launch in U.S. end 2014
Reuters
Fri, 05/24/13 - 10:40 am
Novo Nordisk
liraglutide
obesity
weight loss
Positive Data on Novo Nordisk's N9-GP
Yahoo/Zacks
Wed, 05/22/13 - 09:41 am
Novo Nordisk
N9-GP
hemophilia B
Novo Nordisk completes PhIII hemophilia trial with positive results
Fierce Biotech
Fri, 05/17/13 - 12:01 pm
Novo Nordisk
hemophilia B
N9-GP
Will Obesity Drugs Gain Soon?
Motley Fool
Wed, 05/15/13 - 09:50 am
obesity
Novo Nordisk
Arena Pharmaceuticals
Vivus
Orexigen
Belviq
Contrave
Qsymia
Victoza
Victoza weight-loss nod could rescue Novo from Tresiba delay, CEO says
Fierce Pharma
Thu, 05/9/13 - 09:48 am
Novo Nordisk
Victoza
Tresiba
diabetes
Novo Nordisk First-Quarter Profit Climbs on Insulins, Victoza
Bloomberg
Wed, 05/1/13 - 09:04 am
Novo Nordisk
earnings
Trounce the Market With This Diabetes Care Company
Motley Fool
Mon, 04/29/13 - 10:46 am
diabetes
Novo Nordisk
Novo Nordisk Unveils New U.S. Headquarters
Yahoo
Fri, 04/19/13 - 12:25 pm
Novo Nordisk
Pages
« first
‹ previous
…
49
50
51
52
53
54
55
56
57
…
next ›
last »